Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 11Gastrointestinal 7Thoracic 5Dermatologic 5Genitourinary 4Head & Neck 3Gynecologic 3Lymphoid 2CNS 2Breast 2Sarcoma 1Plasma cell 1Other neoplasm 1Other 1Myeloid 1

Conditions

Prostatic Neoplasms 57Carcinoma, Renal Cell 18Urinary Bladder Neoplasms 13Neoplasm Metastasis 8Sarcoma 7Ovarian Neoplasms 6Melanoma 6Glioma 6Breast Neoplasms 6Wilms Tumor 5Uterine Cervical Neoplasms 5Pancreatic Neoplasms 5Neuroectodermal Tumors, Primitive, Peripheral 5Neuroblastoma 5Lymphoma, Non-Hodgkin 5Kidney Neoplasms 5Carcinoma, Transitional Cell 5Rhabdoid Tumor 4Neoplasms 4Medulloblastoma 4Lung Neoplasms 4Histiocytosis, Langerhans-Cell 4Hepatoblastoma 4Ependymoma 4Colorectal Neoplasms 4Clear-cell metastatic renal cell carcinoma 4Central Nervous System Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Urethral Neoplasms 3Ureteral Neoplasms 3

Interventions

pembrolizumab 28Docetaxel 21Gemcitabine 19Nivolumab 15Paclitaxel 13Prednisone 12Leuprolide 11pazopanib 10Radiotherapy 10Cisplatin 10Sunitinib 9Sorafenib 9Ipilimumab 8Blood Specimen Collection 8Bevacizumab 8avelumab 7atezolizumab 7Therapeutics 7Thalidomide 7Cyclophosphamide 7Carboplatin 7Standard of Care 6Radiation 6Mitomycin 6Interleukin-2 6Cetuximab 6Axitinib 6padeliporfin 5enzalutamide 5cemiplimab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neoplasms × Biopsy × Genitourinary × Clear all
NCT07327489 2026-01-08

ELEPHAS-05

Elephas

Recruiting
2,000 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05655715 2024-10-16

CheckPRO

Herlev and Gentofte Hospital

Phase 2 Completed
90 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00900302 2016-02-10

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

OHSU Knight Cancer Institute

Completed
98 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Melanoma, Neoplasms, Neoplasms, Unknown Primary, Penile Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Vulvar Neoplasms, Breast Neoplasms, Male

NCT00416390 2013-09-20

Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia

National Cancer Institute (NCI)

Phase NA Completed
120 enrolled
Genitourinary

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡